Why CAR-T cell therapy is new frontier in cancer care [Times Nation]

Guardado en:

Detalles Bibliográficos
Publicado en:	The Times of India (Online) (Feb 16, 2024)
Autor principal:	Why is NexCAR19 at centre stageIt is technically just another brand offering CART cell therapy the breakthrough that got American scientist James P Allison
Otros Autores:	Japanese physician Tasuku Honjo the 2018 Nobel Prize in Medicine after more than two decades of work Moreover its 12 years since the first patient Emily Whitehead who was six then got CART cells in their then experimental avatar for relapsed leukaemia at the Childrens Hospital of Philadelphia The answer lies in NexCAR19s tags its possibly the least expensive CART cell therapy in the world at the moment, its homegrown TOI explains
Publicado:	Bennett, Coleman & Company Limited
Materias:	United States > US India Lymphocytes Hospitals Oncology Immunotherapy Cancer therapies Pediatrics
Acceso en línea:	Citation Full Text
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!